SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000947871-18-000493
Filing Date
2018-06-06
Accepted
2018-06-06 18:16:17
Documents
1
Period of Report
2018-06-04

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT ss95079_4.html 4  
1 OWNERSHIP DOCUMENT ss95079_4.xml 4 8223
  Complete submission text file 0000947871-18-000493.txt   9879
Mailing Address C/O ANTHERA PHARMACEUTICALS, INC. 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address
Thompson Peter A. (Reporting) CIK: 0001357522 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37368 | Film No.: 18884790

Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Issuer) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)